Contrast agents for molecular-level fMRI

fMRI: From Nuclear Spins to Brain Functions

Volumn , Issue , 2015, Pages 865-894

  Jasanoff, Alan ^a  

^a Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST AGENT; MOLECULAR LEVELS;

EID: 84955077168     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4899-7591-1_29     Document Type: Chapter

References (146)

1. Abragam A, Goldman M (1978) Principles of dynamic nuclear polarisation. Rep Prog Phys 41:395-467
2. Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E (2009) Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res 42:822-831
3. Allen MJ, Meade TJ (2004) Magnetic resonance contrast agents for medical and molecular imaging. Met Ions Biol Syst 42:1-38
4. Allen MJ, MacRenaris KW, Venkatasubramanian PN, Meade TJ (2004) Cellular delivery of MRI contrast agents. Chem Biol 11:301-307
5. Angelovski G, Fouskova P, Mamedov I, Canals S, Toth E, Logothetis NK (2008) Smart magnetic resonance imaging agents that sense extracellular calcium fluctuations. ChemBioChem 9:1729-1734
6. Aoki I, Wu YJ, Silva AC, Lynch RM, Koretsky AP (2004) In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage 22:1046-1059
7. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K (2003) Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 100:10158-10163
8. Atanasijevic T, Shusteff M, Fam P, Jasanoff A (2006) Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin. Proc Natl Acad Sci U S A 103:14707-14712
9. Atanasijevic T, Zhang XA, Lippard SJ, Jasanoff A (2010) MRI sensing based on the displacement of paramagnetic ions from chelated complexes. Inorg Chem 49:2589-2591
10. Bandettini P, Petridou N, Bodurka J (2005) Direct detection of neuronal activity with MRI: fantasy, possibility, or reality? Appl Magn Reson 29:65-88
11. Belliveau JW, Kennedy DN, Jr, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, Vevea JM, Brady TJ, Rosen BR (1991) Functional mapping of the human visual cortex by magnetic resonance imaging. Science 254:716-719.
12. Bennett KM, Shapiro EM, Sotak CH, Koretsky AP (2008) Controlled aggregation of ferritin to modulate MRI relaxivity. Biophys J 95:342-351
13. Berger S, Schurer L, Hartl R, Messmer K, Baethmann A (1995) Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol. Neurosurgery 37:98-107; discussion 107-108
14. Bloch I, Hansen WW, Packard M (1946) The nuclear induction experiment. Phys Rev 70:474
15. Bloembergen NJ (1957) Proton relaxation times in paramagnetic solutions. J Chem Phys 27: 572-573
16. Bloembergen NJ, Morgan LO (1961) Proton relaxation times in paramagnetic solutions: effects of electron spin relaxation. J Chem Phys 34:842-850
17. Bloembergen NJ, Purcell EM, Pound RV (1948) Relaxation effects in nuclear magnetic resonance absorption. Phys Rev 73:679
18. Bloom JD, Meyer MM, Meinhold P, Otey CR, MacMillan D, Arnold FH (2005) Evolving strategies for enzyme engineering. Curr Opin Struct Biol 15:447-452
19. Boutry S, Burtea C, Laurent S, Toubeau G, Vander Elst L, Muller RN (2005) Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magn Reson Med 53:800-807
20. Brunner E, Haake M, Kaiser L, Pines A, Reimer JA (1999) Gas flow MRI using circulating laserpolarized 129Xe. J Magn Reson 138:155-159
21. Caravan P, Farrar CT, Frullano L, Uppal R (2009) Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imaging 4:89-100
22. Carr DH, Brown J, Bydder GM, Weinmann HJ, Speck U, Thomas DJ, Young IR (1984) Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet 1: 484-486
23. Chesler M (2003) Regulation and modulation of pH in the brain. Physiol Rev 83:1183-1221
24. Clayton DF (2000) The genomic action potential. Neurobiol Learn Mem 74:185-216
25. Cohen B, Dafni H, Meir G, Harmelin A (2005) Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7:109-117
26. Cohen B, Ziv K, Plaks V, Israely T (2007a) MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med 13:498-503
27. Cohen B, Ziv K, Plaks V, Israely T, Kalchenko V, Harmelin A, Benjamin LE, Neeman M (2007b) MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med 13:498-503
28. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM (2005) Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 53:999-1005
29. Datta A, Hooker JM, Botta M, Francis MB, Aime S, Raymond KN (2008) High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents. J Am Chem Soc 130:2546-2552
30. De Leon-Rodriguez LM, Lubag AJ, Malloy CR, Martinez GV, Gillies RJ, Sherry AD (2009) Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res 42:948-957
31. Dementyev AE, Cory DG, Ramanathan C (2008) Dynamic nuclear polarization in silicon microparticles. Phys Rev Lett 100:127601
32. Elkassabany NM, Bhatia J, Deogaonkar A, Barnett GH, Lotto M, Maurtua M, Ebrahim Z, Schubert A, Ference S, Farag E (2008) Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review. J Neurosurg Anesthesiol 20:45-48
33. Eschenko O, Canals S, Simanova I, Beyerlein M, Murayama Y, Logothetis NK (2010a) Mapping of functional brain activity in freely behaving rats during voluntary running using manganeseenhanced MRI: implication for longitudinal studies. Neuroimage 49:2544-2555
34. Eschenko O, Canals S, Simanova I, Logothetis NK (2010b) Behavioral, electrophysiological and histopathological consequences of systemic manganese administration in MEMRI. Magn Reson Imaging 28:1165-1174
35. Esqueda AC, Lopez JA, Andreu-de-Riquer G, Alvarado-Monzon JC, Ratnakar J, Lubag AJ, Sherry AD, De Leon-Rodriguez LM (2009) A new gadolinium-based MRI zinc sensor. J Am Chem Soc 131:11387-11391
36. Frank S, Lauterbur PC (1993) Voltage-sensitive magnetic gels as magnetic resonance monitoring agents. Nature 363:334-336
37. 1 processes. J Chem Phys 68:4034-4037
38. Gallagher FA, Kettunen MI, Day SE, Hu DE, Ardenkjaer-Larsen JH, Zandt R, Jensen PR, Karlsson M, Golman K, Lerche MH et al. (2008) Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature 453:940-943
39. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang S, Gillies RJ (2006) High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn Reson Med 55:309-315
40. Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET (2005) A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11:450-454
41. Gilad AA, McMahon MT, Walczak P, Winnard PT Jr, Raman V, van Laarhoven HW, Skoglund CM, Bulte JW, van Zijl PC (2007a) Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 25:217-219
42. Gilad AA, Winnard PT Jr, van Zijl PC, Bulte JW (2007b) Developing MR reporter genes: promises and pitfalls. NMR Biomed 20:275-290
43. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA (2004) pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag 23:57-64
44. Gillis P, Moiny F, Brooks RA (2002) On T(2)-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med 47:257-263
45. Goldhawk DE, Lemaire C, McCreary CR, McGirr R, Dhanvantari S, Thompson RT, Figueredo R, Koropatnick J, Foster P, Prato FS (2009) Magnetic resonance imaging of cells overexpressing MagA, an endogenous contrast agent for live cell imaging. Mol Imaging 8:129-139
46. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I (2003) Molecular imaging with endogenous substances. Proc Natl Acad Sci U S A 100:10435-10439
47. Golman K, in't Zandt R, Thaning M (2006) Real-time metabolic imaging. Proc Natl Acad Sci U S A 103:11270-11275
48. Hanaoka K, Kikuchi K, Urano Y, Narazaki M, Yokawa T, Sakamoto S, Yamaguchi K, Nagano T (2002) Design and synthesis of a novel magnetic resonance imaging contrast agent for selective sensing of zinc ion. Chem Biol 9:1027-1032.
49. Harel N, Uğurbil K, Uludağ K, Yacoub E (2006) Frontiers of brain mapping using MRI. J Magn Reson Imaging 23:945-957
50. Higuchi M, Iwata N, Matsuba Y, Sato K, Sasamoto K, Saido TC (2005) 19F and 1H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 8:527-533
51. Himmelreich U, Hoehn M (2008) Stem cell labeling for magnetic resonance imaging. Minim Invasive Ther Allied Technol 17:132-142
52. Howles GP, Qi Y, Johnson GA (2010) Ultrasonic disruption of the blood-brain barrier enables in vivo functional mapping of the mouse barrel field cortex with manganese-enhanced MRI. Neuroimage 50:1464-1471
53. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N (2005) Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24:12-20
54. Jasanoff A (2005) Functional MRI using molecular imaging agents. Trends Neurosci 28:120-126
55. Jasanoff A (2007a) Bloodless FMRI. Trends Neurosci 30:603-610
56. Jasanoff A (2007b) MRI contrast agents for functional molecular imaging of brain activity. Curr Opin Neurobiol 17:593-600
57. Jonischkeit T, Bommerich U, Stadler J, Woelk K, Niessen HG, Bargon J (2006) Generating long-lasting 1H and 13C hyperpolarization in small molecules with parahydrogen-induced polarization. J Chem Phys 124:201109
58. Josephson L, Tung CH, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186-191
59. Josephson L, Perez JM, Weissleder R (2001) Magnetic nanosensors for the detection of oligonucleotide sequences. Angew Chem Int Ed Engl 40:3204-3206
60. Kim D-H, Zeng H, Ng TC, Brazel CS (2009) T1 and T2 relaxivities of succimer-coated MFe23+O4 (M=Mn2+, Fe2+and Co2+) inverse spinel ferrites for potential use as phase-contrast agents in medical MRI. J Magn Magn Mater 321:3899-3904
61. Koretsky AP, Silva AC (2004) Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 17:527-531
62. Lauffer RB (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87:901-927
63. Le Bihan D (2007) The 'wet mind': water and functional neuroimaging. Phys Med Biol 52:R57-R90
64. 2: dose-dependent and temporal evolution of T1 contrast. Magn Reson Med 53:640-648
65. Lee J-H, Huh Y-M, Jun Y-w, Seo J-w, Jang J-t, Song H-T, Kim S, Cho E-J, Yoon H-G, Suh J-S et al. (2007) Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13:95-99
66. Lee T, Zhang XA, Dhar S, Faas H, Lippard SJ, Jasanoff A (2010) In vivo imaging with a cellpermeable porphyrin-based MRI contrast agent. Chem Biol 17:665-673
67. Lelyveld VS, Atanasijevic T, Jasanoff A (2010) Challenges for molecular neuroimaging with MRI. Int J Imaging Syst Technol 20:71-79
68. Li W, Fraser SE, Meade TJ (1999) A calcium-sensitive magnetic resonance imaging contrast agent. J Am Chem Soc 121:1413-1414
69. Li WH, Parigi G, Fragai M, Luchinat C, Meade TJ (2002) Mechanistic studies of a calciumdependent MRI contrast agent. Inorg Chem 41:4018-4024.
70. Lin YJ, Koretsky AP (1997) Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med 38:378-388.
71. Liu CH, Kim YR, Ren JQ, Eichler F, Rosen BR, Liu PK (2007) Imaging cerebral gene transcripts in live animals. J Neurosci 27:713-722
72. Logothetis NK (2008) What we can do and what we cannot do with fMRI. Nature 453:869-878
73. Logothetis NK, Wandell BA (2004) Interpreting the BOLD signal. Annu Rev Physiol 66:735-769
74. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ (2000a) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18:321-325 [In Process Citation]
75. Louie AY, Hüber MM, Ahrens ET, Rothbächer U, Moats R, Jacobs RE, Fraser SE, Meade TJ (2000b) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18:321-325
76. Major JL, Parigi G, Luchinat C, Meade TJ (2007) The synthesis and in vitro testing of a zincactivated MRI contrast agent. Proc Natl Acad Sci U S A 104:13881-13886
77. Mandeville JB, Marota JJ, Kosofsky BE, Keltner JR, Weissleder R, Rosen BR, Weisskoff RM (1998) Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 39:615-624.
78. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA (2006) Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5 T and 3 T. Magn Reson Med 55:126-135
79. Mansson S, Johansson E, Magnusson P, Chai CM, Hansson G, Petersson JS, Stahlberg F, Golman K (2006) (13)C imaging-a new diagnostic platform. Eur Radiol 16:57-67
80. Mardor Y, Rahav O, Zauberman Y, Lidar Z, Ocherashvilli A, Daniels D, Roth Y, Maier SE, Orenstein A, Ram Z (2005) Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res 65:6858-6863
81. 19F NMR of perfluorocarbons. Artif Cells Blood Substit Immobil Biotechnol 22:1141-1153
82. Matsumoto Y, Jasanoff A (2008) T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations. Magn Reson Imaging 26:994-998
83. McCarney ER, Armstrong BD, Lingwood MD, Han S (2007) Hyperpolarized water as an authentic magnetic resonance imaging contrast agent. Proc Natl Acad Sci U S A 104:1754-1759
84. McMahon MT, Gilad AA, DeLiso MA, Berman SM, Bulte JW, van Zijl PC (2008) New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med 60:803-812
85. Mills PH, Ahrens ET (2009) Enhanced positive-contrast visualization of paramagnetic contrast agents using phase images. Magn Reson Med 62(5):1349-1355
86. Mishra A, Fouskova P, Angelovski G, Balogh E, Mishra AK, Logothetis NK, Toth E (2008) Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd(3+) complexes: an attempt towards calcium-sensitive MRI contrast agents. Inorg Chem 47:3460
87. Mizukami S, Takikawa R, Sugihara F, Hori Y, Tochio H, Walchli M, Shirakawa M, Kikuchi K (2008) Paramagnetic relaxation-based 19f MRI probe to detect protease activity. J Am Chem Soc 130:794-795
88. Moats RA, Fraser SE, Meade TJ (1997) A "smart" magnetic resonance imaging agent that reports on specific enzyme activity. Angew Chem Int Ed Engl 36:726-728
89. Moffat BA, Reddy GR, McConville P, Hall DE, Chenevert TL, Kopelman RR, Philbert M, Weissleder R, Rehemtulla A, Ross BD (2003) A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. Mol Imaging 2:324-332
90. Moller HE, Chen XJ, Saam B, Hagspiel KD, Johnson GA, Altes TA, de Lange EE, Kauczor HU (2002) MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 47:1029-1051
91. Mountford CE, Stanwell P, Lin A, Ramadan S, Ross B (2010) Neurospectroscopy: the past, present and future. Chem Rev 110:3060-3086
92. Muller RN, Roch A, Colet J-M, Ouakssim A, Gillis P (2001). Particulate magnetic contrast agents. In: Merbach AE, Toth E (eds) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, New York
93. Neuwelt EA, Rapoport SI (1984) Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc 43:214-219
94. Neuwelt EA, Balaban E, Diehl J, Hill S, Frenkel E (1983) Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery 12:662-671
95. Ogawa S, Lee TM, Kay AR, Tank DW (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 87:9868-9872.
96. Pardridge WM (2003) Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv 3:90-105, 151
97. Pardridge WM (2008) Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug Chem 19:1327-1338
98. Pautler RG, Koretsky AP (2002) Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage 16:441-448.
99. Pautler RG, Silva AC, Koretsky AP (1998) In vivo neuronal tract tracing using manganeseenhanced magnetic resonance imaging. Magn Reson Med 40:740-748.
100. Perez JM, Josephson L, O'Loughlin T, Hogemann D, Weissleder R (2002) Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 20:816-820
101. Perez-Torres CJ, Massaad CA, Hilsenbeck SG, Serrano F, Pautler RG (2010) In vitro and in vivo magnetic resonance imaging (MRI) detection of GFP through magnetization transfer contrast (MTC). Neuroimage 50:375-382
102. Perlstein B, Ram Z, Daniels D, Ocherashvilli A, Roth Y, Margel S, Mardor Y (2008) Convectionenhanced delivery of maghemite nanoparticles: increased efficacy and MRI monitoring. Neuro Oncol 10:153-161
103. Porcari P, Capuani S, D'Amore E, Lecce M, La Bella A, Fasano F, Campanella R, Migneco LM, Pastore FS, Maraviglia B (2008) In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT). Phys Med Biol 53:6979-6989
104. Que EL, Chang CJ (2009) Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicine. Chem Soc Rev 39:51-60
105. Roch A, Gossuin Y, Muller RN, Gillis P (2005) Superparamagnetic colloid suspensions: water magnetic relaxation and clustering. J Magn Magn Mater 293:532-539
106. Ross BD, Bhattacharya P, Wagner S, Tran T, Sailasuta N (2009) Hyperpolarized MR imaging: neurologic applications of hyperpolarized metabolism. Am J Neuroradiol 31:24-33
107. Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW (2008) In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med 60:1506-1511
108. Saini S, Ferrucci JT (1988) Ferrite particles as an MR contrast agent. Radiology 169:656
109. Saleem KS, Pauls JM, Augath M, Trinath T, Prause BA, Hashikawa T, Logothetis NK (2002) Magnetic resonance imaging of neuronal connections in the macaque monkey. Neuron 34: 685-700
110. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W (1998) Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 29:1550-1555
111. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A 101:10901-10906
112. Shapiro MG, Atanasijevic T, Faas H, Westmeyer GG, Jasanoff A (2006) Dynamic imaging with MRI contrast agents: quantitative considerations. Magn Reson Imaging 24:449-462
113. Shapiro MG, Szablowski JO, Langer R, Jasanoff A (2009) Protein nanoparticles engineered to sense kinase activity in MRI. J Am Chem Soc 131(7):2484-2486
114. Shapiro MG, Westmeyer GG, Romero PA, Szablowski JO, Kuster B, Shah A, Otey CR, Langer R, Arnold FH, Jasanoff A (2010) Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine. Nat Biotechnol 28:264-270
115. Sherry AD, Woods M (2008) Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng 10:391-411
116. Shmuel A, Yacoub E, Chaimow D, Logothetis NK, Uğurbil K (2007) Spatio-temporal point-spread function of fMRI signal in human gray matter at 7 Tesla. Neuroimage 35:539-552
117. Sibson NR, Blamire AM, Bernades-Silva M, Laurent S, Boutry S, Muller RN, Styles P, Anthony DC (2004) MRI detection of early endothelial activation in brain inflammation. Magn Reson Med 51:248-252
118. Silva AC, Lee JH, Aoki I, Koretsky AP (2004) Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed 17:532-543
119. Sitharaman B, Wilson LJ (2006) Gadonanotubes as new high-performance MRI contrast agents. Int J Nanomedicine 1:291-295
120. 19F NMR of fluorine-labeled chelators. Proc Natl Acad Sci U S A 80: 7178-7182
121. Solomon I (1955) Relaxation processes in a system of two spins. Phys Rev 99:559-565
122. Song AW, Takahashi AM (2001) Lorentz effect imaging. Magn Reson Imaging 19:763-767
123. Sosnovik DE, Weissleder R (2007) Emerging concepts in molecular MRI. Curr Opin Biotechnol 18:4-10
124. Sosnovik DE, Nahrendorf M, Weissleder R (2008) Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol 103:122-130
125. Sun PZ, Schoening ZB, Jasanoff A (2003) In vivo oxygen detection using exogenous hemoglobin as a contrast agent in magnetic resonance microscopy. Magn Reson Med 49:609-614
126. Thorek DLJ, Chen AK, Czupryna J, Tsourkas A (2006) Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34:23-38
127. Toth E, Helm L, Merbach AE (2001). Relaxivity of gadolinium(III) complexes: theory and mechanism. In: Merbach AE, Toth E (eds) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, New York
128. Tsien RY (1998) The green fluorescent protein. Annu Rev Biochem 67:509-544.
129. Vanzetta I, Hildesheim R, Grinvald A (2005) Compartment-resolved imaging of activity-dependent dynamics of cortical blood volume and oximetry. J Neurosci 25:2233-2244
130. von Maltzahn G, Min DH, Zhang Y, Park JH, Harris TJ, Sailor M, Bhatia SN (2007) Nanoparticle self-assembly directed by antagonistic kinase and phosphatase activities. Adv Mater 19: 3579-3583
131. Vykhodtseva N, McDannold N, Hynynen K (2008) Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. Ultrasonics 48:279-296
132. Ward KM, Aletras AH, Balaban RS (2000) A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 143:79-87
133. Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 142:619-624
134. Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H (2003) Tissue-specific MR contrast agents. Eur J Radiol 46:33-44
135. Werner EJ, Datta A, Jocher CJ, Raymond KN (2008) High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew Chem Int Ed Engl 47:8568-8580
136. Westmeyer GG, Jasanoff A (2007) Genetically controlled MRI contrast mechanisms and their prospects in systems neuroscience research. Magn Reson Imaging 25:1004-1010
137. Westmeyer GG, Durocher Y, Jasanoff A (2010) A secreted enzyme reporter system for MRI. Angew Chem Int Ed Engl 49:3909-3911
138. Yu JX, Kodibagkar VD, Cui W, Mason RP (2005a) 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr Med Chem 12:819-848
139. Yu X, Wadghiri YZ, Sanes DH, Turnbull DH (2005b) In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat Neurosci 8:961-968
140. Zabow G, Dodd S, Moreland J, Koretsky A (2008) Micro-engineered local field control for highsensitivity multispectral MRI. Nature 453:1058-1063
141. Zhang S, Merritt M, Woessner DE, Lenkinski RE, Sherry AD (2003) PARACEST agents: modulating MRI contrast via water proton exchange. Acc Chem Res 36:783-790
142. Zhang X-A, Lovejoy KS, Jasanoff A, Lippard SJ (2007a) Water-soluble porphyrins as a dualfunction molecular imaging platform for MRI and fluorescence zinc sensing. Proc Natl Acad Sci U S A 104:10780-10785
143. Zhang XA, Lovejoy KS, Jasanoff A, Lippard SJ (2007b) Water-soluble porphyrins as a dualfunction molecular imaging platform for MRI and fluorescence zinc sensing. Proc Natl Acad Sci U S A 104:10780-10785
144. Zhou J, Payen JF, Wilson DA, Traystman RJ, Van Zijl PC (2003) Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 9:1085-1090
145. Zhou J, Wilson DA, Sun PZ, Klaus JA, Van Zijl PC (2004) Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn Reson Med 51:945-952
146. Zurkiya O, Chan AW, Hu X (2008) MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med 59:1225-1231